Theravance Biopharma (TBPH) Work In Process (2013 - 2018)

Theravance Biopharma (TBPH) has 5 years of Work In Process data on file, last reported at $3.6 million in Q3 2018.

• On a quarterly basis, Work In Process rose 379.89% year-over-year to $3.6 million in Q3 2018; TTM through Sep 2018 was $3.6 million, a 379.89% increase from a year earlier, with the FY2017 full-year figure at $66000.0, down 97.49% from the prior year.
• Work In Process for Q3 2018 stood at $3.6 million, up from $3.3 million in the prior quarter.
• Over the last five years, Work In Process for TBPH reached as high as $3.6 million in Q3 2018 and fell as low as $66000.0 in Q4 2017.
• Historically, Work In Process has averaged $1.9 million across 4 years, with a median of $2.0 million in 2018.
• Across the five-year window, Work In Process slumped 97.49% in 2017 and soared 379.89% in 2018, its largest moves.
• Year by year, Work In Process stood at $145000.0 in 2014, then jumped by 1711.72% to $2.6 million in 2016, then slumped by 97.49% to $66000.0 in 2017, then jumped by 5396.97% to $3.6 million in 2018.
• Per Business Quant data, the three most recent Work In Process figures were $3.6 million in Q3 2018, $3.3 million in Q2 2018, and $2.0 million in Q1 2018.